Use of Hydroxychloroquine, Remdesivir, and Dexamethasone Among Adults Hospitalized With COVID-19 in the United States
Author(s) -
Hemalkumar B. Mehta,
Huijun An,
Kathleen M. Andersen,
Omar Mansour,
Vithal Madhira,
Emaan Rashidi,
Benjamin Bates,
Soko Setoguchi,
Corey Joseph,
Paul T. Kocis,
Richard A. Moffitt,
Tellen D. Bennett,
Christopher G. Chute,
Brian T. Garibaldi,
G. Caleb Alexander
Publication year - 2021
Publication title -
annals of internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.839
H-Index - 390
eISSN - 1539-3704
pISSN - 0003-4819
DOI - 10.7326/m21-0857
Subject(s) - hydroxychloroquine , medicine , dexamethasone , cohort , covid-19 , cohort study , retrospective cohort study , pediatrics , disease , infectious disease (medical specialty)
Relatively little is known about the use patterns of potential pharmacologic treatments of COVID-19 in the United States.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom